Cargando…

Details of out-field regional recurrence after involved-field irradiation with concurrent chemotherapy for locally advanced esophageal squamous cell carcinoma

BACKGROUND: The purpose of this study was to describe the patterns of out-field regional recurrence after involved-field irradiation (IFI) in definitive concurrent chemoradiotherapy (CCRT) for locally advanced esophageal squamous cell carcinoma (LA-ESCC) and identify the possible risk factors. PATIE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaoli, Yu, Jinming, Li, Minghuan, Zhu, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883805/ https://www.ncbi.nlm.nih.gov/pubmed/27284256 http://dx.doi.org/10.2147/OTT.S100946

Ejemplares similares

Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2014)

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice
por: Li, Minghuan, et al.
Publicado: (2016)

Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute
por: Jing, Wang, et al.
Publicado: (2015)

Correction: Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute
por: Jing, Wang, et al.
Publicado: (2016)

Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial
por: Li, Hui, et al.
Publicado: (2022)

Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer
por: Zhang, Jian, et al.
Publicado: (2012)

Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis
por: Cheng, Yun-jie, et al.
Publicado: (2018)

Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis
por: Wang, Xiaoyue, et al.
Publicado: (2017)

Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study
por: Yamashita, Hideomi, et al.
Publicado: (2015)

Three-dimensional conformal radiation for esophageal squamous cell carcinoma with involved-field irradiation may deliver considerable doses of incidental nodal irradiation
por: Ji, Kai, et al.
Publicado: (2012)

Prophylactic extended-field irradiation with concurrent chemotherapy for pelvic lymph node-positive cervical cancer
por: Oh, Jinju, et al.
Publicado: (2017)

Involved-Field Radiotherapy versus Elective Nodal Irradiation in Combination with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Prospective Randomized Study
por: Chen, Ming, et al.
Publicado: (2013)

Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients
por: Liu, Ao, et al.
Publicado: (2021)

Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation
por: Zhu, Yingming, et al.
Publicado: (2016)

Elective nodal irradiation versus involved-field irradiation for stage II–IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes
por: Wang, Jianing, et al.
Publicado: (2023)

Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT
por: Xiang, Geng, et al.
Publicado: (2023)

A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR
por: Wang, Chunsheng, et al.
Publicado: (2020)

The flow-metabolism ratio might predict treatment response and survival in patients with locally advanced esophageal squamous cell carcinoma
por: Zhao, Kewei, et al.
Publicado: (2020)

Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma
por: Pao, Tzu-Hui, et al.
Publicado: (2021)

Radiotherapy for esophageal carcinoma: dose, response and survival
por: Luo, Yijun, et al.
Publicado: (2017)

Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern
por: Bao, Yong, et al.
Publicado: (2013)

Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy
por: Xu, Xiujuan, et al.
Publicado: (2019)

Elective nodal irradiation provides a superior therapeutic modality for lymph node positivity esophageal squamous cell carcinoma patients receiving definitive radiotherapy versus involved-field irradiation
por: Li, Qiaofang, et al.
Publicado: (2019)

The expression of p‐p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance
por: Wang, Zhe, et al.
Publicado: (2019)

Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis
por: Liu, Tingting, et al.
Publicado: (2019)

Concurrent Recording of Co-localized Electroencephalography and Local Field Potential in Rodent
por: Kang, Sungmin, et al.
Publicado: (2017)

A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy
por: Wang, Peiliang, et al.
Publicado: (2021)

Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
por: Zhou, Xi-Lei, et al.
Publicado: (2021)

Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma
por: Zhao, Kewei, et al.
Publicado: (2020)

Detailed Field Distribution in CMS Winding
por: Farinon, S, et al.
Publicado: (2000)

The role of involved field irradiation versus elective nodal irradiation in definitive radiotherapy or chemoradiotherapy for esophageal cancer- a systematic review and meta-analysis
por: Wang, Hesong, et al.
Publicado: (2022)

Comparison between the effects of elective nodal irradiation and involved‐field irradiation on long‐term survival in thoracic esophageal squamous cell carcinoma patients: A prospective, multicenter, randomized, controlled study in China
por: Lyu, Jiahua, et al.
Publicado: (2020)

Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy
por: Zhang, Jingze, et al.
Publicado: (2018)

Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
por: Ali, Elsayed M, et al.
Publicado: (2011)

Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemo-radiotherapy for locally-advanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival
por: Chen, Xianyan, et al.
Publicado: (2023)

Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study
por: Altay-Langguth, Alev, et al.
Publicado: (2021)

Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2020)

Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II–III Esophageal Squamous Cell Carcinoma
por: Zhu, Huiping, et al.
Publicado: (2022)

Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
por: Chen, Chih-Yi, et al.
Publicado: (2018)

Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis
por: Zhao, Kaikai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_464865anfrekgndam7dvt7j04e